| Financial Year |
March 31 2023 |
| Monetary Funds |
63,435,639,000.00 |
| Held-for-trading Financial Assets |
384,853,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
16,306,215,000.00 |
| Advances to Suppliers |
127,046,000.00 |
| Other Receivables |
1,298,929,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
45,934,056,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,080,001,000.00 |
| Total Current Assets |
141,533,786,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,579,757,000.00 |
| Long-term Equity Investment |
1,774,272,000.00 |
| Investment Properties |
2,010,627,000.00 |
| Fixed Assetes |
12,778,439,000.00 |
| Under-construction Projects |
1,124,630,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,965,719,000.00 |
| R&D expenses |
2,813,388,000.00 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,428,766,000.00 |
| Other Non-Current Assets |
7,030,050,000.00 |
| Sub-Total of Non-Current Assets |
42,459,614,000.00 |
| Total Assets |
183,993,400,000.00 |
| Short-Term Loans |
10,409,563,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,156,624,000.00 |
| Accounts Payable |
18,323,685,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,327,590,000.00 |
| Taxes Payable |
1,653,439,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,853,039,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,715,683,000.00 |
| Other Current Liabilities |
4,849,617,000.00 |
| Sub-Total of Current Liabilities |
76,327,486,000.00 |
| Long-term Loans |
37,442,703,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
82,168,000.00 |
| Other Non-Current Liabilities |
4,553,329,000.00 |
| Sub-Total of Non-Current Liabilities |
45,742,456,000.00 |
| Total Liabilities |
122,069,942,000.00 |
| Paid-In Capital(Or Share Stock) |
4,736,588,000.00 |
| Capital Surplus |
25,885,241,000.00 |
| Surplus Reserve |
3,029,811,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
29,950,890,000.00 |
| Minority Stockholder's Interest |
757,282,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
61,166,176,000.00 |
| Owner's Equity（Stockholder's Equity） |
61,923,458,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
183,993,400,000.00 |
